Gastrointestinal Therapy Agents Use

Project Title Gastrointestinal Therapy Agents Use
Date Posted
Friday, September 13, 2013
Project ID
MSY3_STR89
Status
Complete
Deliverables
Description

Summary table assessment of the use of ten selected gastrointestinal (GI) therapies including Aprepitant, Fosaprepitant Dimeglumine, Cimetidine, Dexlansoprazole, Dicyclomine HCL, Lubiprostone, Mesalamine, Nizatidine, and Sucralfate. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.Summary tables are precompiled stratified counts. Queries were executed in July 2012. This report includes data from 16 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
aprepitant
cimetidine
dexlansoprazole
dicyclomine HCL
fosaprepitant dimeglumine
lubiprostone
mesalamine
nizatidine
sucralfate
Population / Cohort
All children 14 years of age or younger
Time Period
2000 - 2011
Assessment Type
Exploratory Analyses
Study Type
Summary Table
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER
Scroll to Top